Phase 3 Immunosuppression Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Assistance Publique - Hôpitaux de Paris170 enrolled2 locationsNCT06694740
Recruiting
Phase 3
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression
Sustained Immunosuppression
University Hospital, Limoges326 enrolled23 locationsNCT06774235
Recruiting
Phase 3
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Fungal InfectionImmunosuppressionDisseminated Histoplasma Capsulatum Infection+1 more
Federal University of Health Science of Porto Alegre279 enrolled5 locationsNCT05814432